<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04911283</url>
  </required_header>
  <id_info>
    <org_study_id>SUEADH</org_study_id>
    <nct_id>NCT04911283</nct_id>
  </id_info>
  <brief_title>Brucella Serology and History of Brucellosis in Patients With Modic Changes Type 1</brief_title>
  <official_title>Mehmet Akif İnan Education and Research Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Veysel Delen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sanliurfa Mehmet Akif Inan Education and Research Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: This study aims to examine Brucella serology and history of brucellosis in&#xD;
      patients with lumbar Modic changes (MCs) type 1, considering results from cross-sectional and&#xD;
      case-control comparisons.&#xD;
&#xD;
      Design: In comparative cross-sectional design, MCs type 1 patients (study group) and MCs type&#xD;
      2 patients (comparator group) were examined in terms of Brucella serology by using&#xD;
      agglutination with Coombs test. In addition, in comparative case-control design, both of the&#xD;
      MCs groups and age/sex-matched healthy controls were investigated for their medical history&#xD;
      regarding brucellosis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Actual">July 1, 2020</completion_date>
  <primary_completion_date type="Actual">July 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Serology for brucellosis</measure>
    <time_frame>30 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>History of brucellosis</measure>
    <time_frame>7 minutes</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">118</enrollment>
  <condition>Brucellosis</condition>
  <condition>Spinal Degeneration</condition>
  <arm_group>
    <arm_group_label>MCs type 1 patients (study group; n=37)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>MCs type 2 patients (comparator group; n=44)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy controls (n=37)</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Brucella serology test</intervention_name>
    <description>MCs type 1 and type 2 patients were examined in terms of Brucella serology by using agglutination with Coombs test.</description>
    <arm_group_label>MCs type 1 patients (study group; n=37)</arm_group_label>
    <arm_group_label>MCs type 2 patients (comparator group; n=44)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Medical history for brucellosis</intervention_name>
    <description>Both of the MCs groups and healthy controls were investigated for their medical history regarding brucellosis.</description>
    <arm_group_label>MCs type 1 patients (study group; n=37)</arm_group_label>
    <arm_group_label>MCs type 2 patients (comparator group; n=44)</arm_group_label>
    <arm_group_label>healthy controls (n=37)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with MCs and age/sex-matched healthy controls&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with lumbar Modic changes type 1&#xD;
&#xD;
          -  Patients with lumbar Modic changes type 2&#xD;
&#xD;
          -  Participant who given informed consent for the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients aged&lt;18 years&#xD;
&#xD;
          -  History of serious lumbar trauma&#xD;
&#xD;
          -  Lumbar spinal surgery&#xD;
&#xD;
          -  Scoliosis&#xD;
&#xD;
          -  Cooperation disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Veysel Delen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mehmet Akif İnan Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mehmet Akif İnan Hospital</name>
      <address>
        <city>Şanlıurfa</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 25, 2021</study_first_submitted>
  <study_first_submitted_qc>June 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 3, 2021</study_first_posted>
  <last_update_submitted>June 1, 2021</last_update_submitted>
  <last_update_submitted_qc>June 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Sanliurfa Mehmet Akif Inan Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>Veysel Delen</investigator_full_name>
    <investigator_title>Department of Physical Medicine and Rehabilitation</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brucellosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

